
Prolia® (denosumab) for Postmenopausal Osteoporosis
Prolia ® is a prescription medicine used to treat osteoporosis in men and women who will be taking corticosteroid medicines (such as prednisone) for at least six months and are at high …
Prolia: Uses, Dosage, Side Effects, Warnings - Drugs.com
4 days ago · Prolia works by stopping the formation of osteoclasts before they can reach and damage the bone. It binds to RANKL, which is a protein on the membrane of osteoclasts that …
Denosumab (subcutaneous route) - Side effects & uses - Mayo Clinic
Jan 1, 2026 · Denosumab injection is used to treat osteoporosis (thinning of the bones) in women who have an increased risk for fractures after menopause, and osteoporosis in men. It is given …
Denosumab (Prolia, Jubbonti, Stoboclo): Uses, Side Effects
Jul 3, 2024 · Denosumab (Prolia, Jubbonti, Stoboclo) is commonly used to treat osteoporosis, a condition in which the bones are thinner, weaker, and more prone to breakage. Denosumab …
Treatment for Postmenopausal Osteoporosis | Prolia® …
Prolia® is indicated for the treatment of postmenopausal women with osteoporosis at high risk for fracture, defined as a history of osteoporotic fracture, or multiple risk factors for fracture; or …
Prolia (Denosumab Injection): Side Effects, Uses, Dosage ... - RxList
Jun 11, 2025 · Prolia (Denosumab Injection) may treat, side effects, dosage, drug interactions, warnings, patient labeling, reviews, and related medications including drug comparison and …
Prolia Injection (Denosumab): Uses & Side Effects - Cleveland Clinic
Prolia® injection is a brand of denosumab, which treats osteoporosis. Osteoporosis is a condition that weakens your bones, making them more susceptible to fractures.
Prolia is indicated for the treatment of postmenopausal women with osteoporosis at high risk for fracture, defined as a history of osteoporotic fracture, or multiple risk factors for fracture; or...
Denosumab (Prolia) - American College of Rheumatology
Denosumab (Prolia) is a biologic medication used to prevent fragile bones, also known as osteoporosis, and bone fractures. See how to take it and side effects.
FDA Approves Denosumab Biosimilars Boncresa and Oziltus for ...
Dec 31, 2025 · Key Takeaways Boncresa and Oziltus are approved for all indications of Prolia and Xgeva, respectively, addressing osteoporosis and cancer-related bone loss. Prolia's …